Venture Certified
| 혁신성장유형 | 2023-06-07 ~ 2026-06-06 | 20230607030107 | 2023-06-07 |
Revenue CAGR +47.0%
| Item | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 3.1B | 5.1B | 1.4B |
| Operating Profit | -4.8B | -1.5B | -1.1B |
| Net Profit | -3.0B | 0.2B | -1.0B |
| Total Assets | 9.8B | 7.2B | 1.0B |
| Total Liabilities | 9.4B | 7.5B | 1.6B |
| Total Equity | 0.5B | -0.3B | -0.6B |
Debt Ratio 2058.8%: Exceeds 400%, financial soundness risk
Operating Loss: Op. profit -5B
Revenue down 39% YoY
▼ 4.7%
▼ 262.4%
▼ 189.3%
▲ 258.9%
▼ 1390.6%
| Name | Position | Role |
|---|---|---|
| 최항주 | 대표이사 | 대표 |
No Data – Contact
No procurement record or data not yet available| Tax Type | 부가가치세 일반과세자 |
| Status | Cert. flags confirmed (details update after further collection) |
1 Additional Data Sources
{
"address": "세종특별자치시 집현중앙7로",
"ceo_name": "최항주",
"certificate": [
{
"cert_number": "20230607030107",
"changes": "",
"disclosure_date": "2023-06-07",
"first_cert_date": "2023-06-07",
"no": "1",
"type": "혁신성장유형",
"valid_period": "2023-06-07 ~ 2026-06-06"
}
],
"company_name": "(주)그레비티",
"corp_no": "110111-*******",
"financials": {
"2022": {
"capital_stock": 70000000,
"cost_of_sales": 136017000,
"current_assets": 83566000,
"current_liabilities": 155456000,
"gross_profit": 7467000,
"net_income": -99439000,
"net_income_bs": -99439000,
"non_current_assets": 15292000,
"non_current_liabilities": 0,
"non_operating_expenses": 11967000,
"non_operating_income": 21050000,
"operating_profit": -108522000,
"revenue": 143484000,
"sga_expenses": 115989000,
"total_assets": 98858000,
"total_equity": -56598000,
"total_liabilities": 155456000
},
"2023": {
"capital_stock": 70000000,
"cost_of_sales": 175474000,
"current_assets": 658949000,
"current_liabilities": 753050000,
"gross_profit": 331436000,
"net_income": 24089000,
"net_income_bs": 24089000,
"non_current_assets": 61592000,
"non_current_liabilities": 0,
"non_operating_expenses": 20172000,
"non_operating_income": 197987000,
"operating_profit": -153726000,
"revenue": 506910000,
"sga_expenses": 485162000,
"total_assets": 720541000,
"total_equity": -32509000,
"total_liabilities": 753050000
},
"2024": {
"capital_stock": 70000000,
"cost_of_sales": 471014000,
"current_assets": 326827000,
"current_liabilities": 935886000,
"gross_profit": -161012000,
"net_income": -298032000,
"net_income_bs": -298032000,
"non_current_assets": 654518000,
"non_current_liabilities": 0,
"non_operating_expenses": 29340000,
"non_operating_income": 206448000,
"operating_profit": -475140000,
"revenue": 310002000,
"sga_expenses": 314128000,
"total_assets": 981345000,
"total_equity": 45459000,
"total_liabilities": 935886000
}
},
"industry": "물질 검사, 측정 및 분석기구 제조업",
"investment": [],
"main_products": "요당 정량 모니터링기기, 심혈관질환 바이오마커 자동분석기기",
"phone": "070-4706-****",
"years": [
2024,
2023,
2022
]
}